The role of neoadjuvant chemotherapy in the management of metastatic central nervous system germinoma: A meta-analysis.

BACKGROUND The role of neoadjuvant chemotherapy in treating patients with metastatic central nervous system (CNS) germinoma is controversial. METHODS We compared the relapse-free survival (RFS) of different treatment modalities by performing a meta-analysis using published data. We summarized all data using standard descriptive statistics. We used the Kaplan-Meier method to estimate RFS and their corresponding 95% confidence intervals (CIs). We used the log-rank test for the comparison of survival functions. RESULTS We identified 97 patients with a median age at presentation of 15 years (range: 7-38). Sites of metastasis were cerebrospinal fluid (CSF) disease only (n = 12), brain parenchyma (n = 18), spinal cord (n = 9), ventricular and CSF (n = 10), ventricular only (n = 31), and other (n = 17). The 3-year RFS among patients who received any form of radiotherapy was 89% (95% CI: 83-96) compared with 0% for patients who received a chemotherapy-only regimen (p = .001). Five-year RFS among patients who received craniospinal irradiation (CSI) was 92% (95% CI: 84-100) compared with 76.4% (95% CI: 63-90) in the non-CSI group (with or without neoadjuvant chemotherapy) (p = .014). Five-year RFS of patients who received CSI less than 24 Gy with neoadjuvant chemotherapy was 100% compared with 92% (95% CI: 83-100) CSI dose greater than or equal to 24 Gy alone (p = .3). CONCLUSIONS Our analysis does not support avoiding spinal irradiation among patients with radiographic metastatic CNS germinoma. Future studies are needed to confirm whether neoadjuvant chemotherapy will allow a reduction of irradiation dose without compromising survival.

[1]  U. Bartels,et al.  Feasibility of treating pediatric intracranial germ cell tumors in a middle‐income country: The Jordanian experience , 2022, Pediatric blood & cancer.

[2]  H. Sakurai,et al.  Factors influencing craniospinal relapse of intracranial germinoma after complete remission. , 2022, World neurosurgery.

[3]  S. McGovern,et al.  Late Effects of Craniospinal Irradiation Using Electron Spinal Fields for Pediatric Cancer Patients. , 2022, International journal of radiation oncology, biology, physics.

[4]  Yi-Wei Chen,et al.  Bifocal lesions have a poorer treatment outcome than a single lesion in adult patients with intracranial germinoma , 2022, PloS one.

[5]  J. Barnholtz-Sloan,et al.  CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2014-2018. , 2021, Neuro-oncology.

[6]  H. Abe,et al.  Necessity for craniospinal irradiation of germinoma with positive cytology without spinal lesion on MR imaging—A controversy , 2021, Neuro-oncology advances.

[7]  Y. Suh,et al.  Induction chemotherapy reduces radiotherapy dose and volume in the treatment of intracranial germinoma: Results of the SMC-G13 trial. , 2020, International journal of radiation oncology, biology, physics.

[8]  K. Yoo,et al.  Upfront chemotherapy followed by response adaptive radiotherapy for intracranial germinoma: Prospective multicenter cohort study. , 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[9]  J. Mann,et al.  Treatment and outcomes of UK and German patients with relapsed intracranial germ cell tumors following uniform first‐line therapy , 2017, International journal of cancer.

[10]  K. Jung,et al.  Nationwide Population-Based Incidence and Survival Rates of Malignant Central Nervous System Germ Cell Tumors in Korea, 2005-2012 , 2016, Cancer research and treatment : official journal of Korean Cancer Association.

[11]  Yi-Wei Chen,et al.  Neuropsychological functions and quality of life in survived patients with intracranial germ cell tumors after treatment. , 2013, Neuro-oncology.

[12]  D. Frappaz,et al.  SIOP CNS GCT 96: final report of outcome of a prospective, multinational nonrandomized trial for children and adults with intracranial germinoma, comparing craniospinal irradiation alone with chemotherapy followed by focal primary site irradiation for patients with localized disease. , 2013, Neuro-oncology.

[13]  B. Owler,et al.  Paediatric germ cell tumours of the central nervous system: Results and experience from a tertiary-referral paediatric institution in Australia , 2013, Journal of Clinical Neuroscience.

[14]  M. Hata,et al.  Clinical Investigation : Central Nervous System Tumor Treatment Outcomes , Growth Height , and Neuroendocrine Functions in Patients With Intracranial Germ Cell Tumors Treated With Chemoradiation Therapy , 2022 .

[15]  E. Miyaoka,et al.  Primary CNS germ cell tumors in Japan and the United States: an analysis of 4 tumor registries. , 2012, Neuro-oncology.

[16]  Y. Shibamoto,et al.  Bifocal intracranial germinoma: a retrospective analysis of treatment outcomes in 20 patients and review of the literature. , 2012, International journal of radiation oncology, biology, physics.

[17]  U. Bartels,et al.  Longitudinal evaluation of neurocognitive function after treatment for central nervous system germ cell tumors in childhood , 2011, Cancer.

[18]  J. Buckner,et al.  Long-term follow-up of dose-adapted and reduced-field radiotherapy with or without chemotherapy for central nervous system germinoma. , 2010, International journal of radiation oncology, biology, physics.

[19]  S. Khatua,et al.  Treatment of primary CNS germinomatous germ cell tumors with chemotherapy prior to reduced dose whole ventricular and local boost irradiation , 2010, Pediatric blood & cancer.

[20]  J. Wisoff,et al.  Primary chemotherapy for intracranial germ cell tumors: Results of the third international CNS germ cell tumor study , 2010, Pediatric blood & cancer.

[21]  L. Kleinberg,et al.  Pre‐radiation chemotherapy with response‐based radiation therapy in children with central nervous system germ cell tumors: A report from the Children's Oncology Group , 2007, Pediatric blood & cancer.

[22]  P. Strojan,et al.  The role of radiotherapy in the treatment of childhood intracranial germinoma: Long‐term survival and late effects , 2006, Pediatric blood & cancer.

[23]  J. Itami,et al.  Lack of benefit of spinal irradiation in the primary treatment of intracranial germinoma , 2005, Cancer.

[24]  M. Rosenblum,et al.  Intensive cisplatin and cyclophosphamide‐based chemotherapy without radiotherapy for intracranial germinomas: Failure of a primary chemotherapy approach , 2004, Pediatric blood & cancer.

[25]  N. Foreman,et al.  Intracranial Germ Cell Tumors: A Single Institution Experience and Review of the Literature , 2004, Journal of Neuro-Oncology.

[26]  C. Patte,et al.  Combined treatment modality for intracranial germinomas: results of a multicentre SFOP experience , 1999, British Journal of Cancer.

[27]  Y. Shibamoto,et al.  Reduction of the radiation dose for intracranial germinoma: a prospective study. , 1994, British Journal of Cancer.

[28]  J. Mechanick,et al.  Hypothalamic dysfunction following whole-brain irradiation. , 1986, Journal of neurosurgery.

[29]  OUP accepted manuscript , 2021, Neuro-Oncology.

[30]  OUP accepted manuscript , 2021, Neuro-Oncology.

[31]  OUP accepted manuscript , 2021, Neuro-Oncology.

[32]  Abstracts of the 44th Congress of the International Society of Paediatric Oncology (SIOP) 2012, October 5-8, 2012, London, United Kingdom. , 2012, Pediatric blood & cancer.

[33]  E P Frenkel,et al.  Therapeutic dilemma of disseminated CNS germinoma and the potential of increased platinum-based chemotherapy delivery with osmotic blood-brain barrier disruption. , 1994, Pediatric neurosurgery.